New process definition capabilities in PIMS 5.1, further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers.
IDBS is recognized as one of the Top Laboratory Automation Solutions Providers by Pharma Tech Outlook.
Discover how a digital backbone is vital to get transformational insights from your BioPharma development data.
In today’s digital gold rush, data integrity is priceless. Discover how searchable and reusable data can improve efficiency, accelerating drug discovery.
Thinking of upgrading from a standard ELN? Discover the benefits of centralized BioPharma Lifecycle Management platforms compared to standard ELNs.
Learn how advances in digital technology and the tailwinds of external forces offer the pharma industry a chance to break out of this paradox.
Making data a core deliverable means the right people need to collect information and connect disparate data points through a well-structured data backbone.
Explore why digital maturity is key to transparency and collaboration and enabling accurate forecasting throughout the BioPharmaceutical lifecycle.
Explore the benefits of GxP computer systems to improve time-to-value so that companies can speed up the development and manufacture of life-saving drugs.
IDBS reveals new process definition-handling capabilities in PIMS 5.0, which enhance quality assurance and validation for pharma manufacturers.